Becotatug Vedotin Combined With Cetuximab in the Later-line Treatment of Metastatic RAS Wild-type Colorectal Cancer

NCT07490119 · clinicaltrials.gov ↗

PHASE2

Phase

NOT_YET_RECRUITING

Status

31

Enrollment

OTHER

Sponsor class

Conditions

RAS Wild Type mCRC

Interventions

DRUG: Becotatug Vedotin
DRUG: Cetuximab

Sponsor

Fudan University

Collaborators

[object Object]